Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9489446 | 1.00 | — | — | |
| Water SCHEMBL9136338 | 1.00 | — | — | |
| Water SCHEMBL8332252 | 1.00 | — | — | |
| Water SCHEMBL5193902 | 1.00 | — | — | |
| Water SCHEMBL486758 | 1.00 | — | — | |
| Water SCHEMBL409681 | 1.00 | — | — | |
| Water SCHEMBL5595444 | 1.00 | — | — | |
| Water SCHEMBL570871 | 1.00 | — | — | |
| Water SCHEMBL8664030 | 1.00 | — | — | |
| Water SCHEMBL10626151 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693166-A | Municipal sludge pollution-free treatment process and application thereof | 浙江筑微科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116621416-A | Composite sludge conditioner and application thereof | 浙江筑微科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-115742443-A | Production device of three-in-one calcium chewable tablets | 江西华太药业有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-113166614-B | High chemical resistance coating for protection against aggressive environments | 3M创新有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-113166614-A | High chemical resistance coating for protection against aggressive environments | 3M创新有限公司 | 2021-07-23 | — | — | CN | claimed |
| EP-3426232-B1 | A MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) | NLS PHARMACEUTICS AG (CH) | 2021-06-02 | — | — | EP | claimed |
| EP-3654955-A1 | PHARMACEUTICAL COMPOSITIONS | Eli Lilly and Company (US) | 2020-05-27 | — | — | EP | claimed |
| EP-3494098-A1 | FIRE RESISTANT COATING AND HIGH STRENGTH, DENSITY CONTROLLED COLD FUSION CONCRETE CEMENTITIOUS SPRAY APPLIED FIREPROOFING | Geopolymer Solutions LLC (US) | 2019-06-12 | — | — | EP | claimed |
| WO-2019018155-A1 | PHARMACEUTICAL COMPOSITIONS | ELI LILLY AND COMPANY (US) | 2019-01-24 | — | — | WO | claimed |
| EP-3340980-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN HMG-COA REDUCTASE INHIBITOR AND AN ECA INHIBITOR | Les Laboratoires Servier (FR) | 2018-07-04 | — | — | EP | claimed |
| EP-2393516-B1 | STABLE, TASTE AND ODOR MASKED PHARMACEUTICAL COMPOSITIONS COMPRISING N-ACETYLCYSTEINE AND VITAMIN C | BILGIC MAHMUT (TR) | 2015-12-02 | — | — | EP | claimed |
| EP-2393478-B1 | TASTE AND ODOR MASKED PHARMACEUTICAL COMPOSITIONS WITH HIGH BIOAVAILABILITY | BILGIC MAHMUT (TR) | 2015-06-17 | — | — | EP | claimed |
| EP-2394644-B1 | Trimetazidine Formulation With Different Release Profiles | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi (TR) | 2014-07-09 | — | — | EP | claimed |
| EP-2157185-B1 | Process for production of succinic acid, and process for production of ammonium succinate solution | AJINOMOTO KK (JP) | 2014-05-14 | — | — | EP | claimed |
| EP-1660104-B1 | PHARMACEUTICAL FORMULATION COMPRISING LANTHANUM COMPOUNDS | SHIRE HOLDINGS AG (CH) | 2010-03-10 | — | — | EP | claimed |
| EP-1478339-B9 | PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS, IN PARTICULAR TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME | SCHERING CORP (US) | 2009-08-19 | — | — | EP | claimed |
| EP-1478339-B1 | PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS, IN PARTICULAR TEMOZOLOMIDE, PROCESSES OF MAKING AND USING THE SAME | SCHERING CORP (US) | 2008-06-04 | — | — | EP | claimed |
| CN-1863511-A | Dosage forms providing controlled release cholesteryl ester transfer protein inhibitors and immediate release HMG-CoA reductase inhibitors | PFIZER (US) | 2006-11-15 | — | — | CN | claimed |
| EP-1175220-B1 | NANOPARTICULATE EPLERENONE COMPOSITIONS | PHARMACIA CORP (US) | 2005-04-27 | — | — | EP | claimed |
| EP-0991415-B1 | ORALLY ADMINISTRABLE SOLID RIBAVIRIN DOSAGE FORMS AND PROCESS FOR MAKING THEM | SCHERING CORP (US) | 2003-03-12 | — | — | EP | claimed |